Reduction of Helicobacter infection in IL-10-/- mice is dependent on CD4+ T cells but not on mast cells

Helicobacter

Volumn 13, Issue 5, 2008, Pages 361-369

  Velin, Dominique ^a   Bachmann, Daniel ^a   Bouzourene, Hanifa ^a   Michetti, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Helicobacter; Interleukin 10; Mast cell; Vaccine

Indexed keywords

CD4 ANTIBODY; CHOLERA TOXIN; DNA; ESCHERICHIA COLI ENDOTOXIN; HELICOBACTER UREASE BETA SUBUNIT; INTERLEUKIN 10; UREASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENOTYPE; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTERMETHOD COMPARISON; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HELICOBACTER INFECTIONS; INTERLEUKIN-10; KINETICS; MALE; MAST CELLS; MICE; MICE, MUTANT STRAINS;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER FELIS; MUS;

EID: 49749112402     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2008.00614.x     Document Type: Article

References (45)

1. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991 13: 42 59.
2. Sipponen P. Natural history of gastritis and its relationship to peptic ulcer disease. Digestion 1992 51: 70 5.
3. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer-evidence from a prospective investigation. Br Med J 1991 302: 1302 5.
4. Stolte M, Eidt S. Healing gastric MALT lymphomas by eradicating H. pylori. Lancet 1993 342: 568.
5. Robinson K, Loughlin MF, Potter R, Jenks PJ. Host adaptation and immune modulation are mediated by homologous recombination in Helicobacter pylori. J Infect Dis 2005 191: 579 87.
6. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM. Helicobacter pylori flagellin evades Toll-like receptor 5-mediated innate immunity. J Infect Dis 2004 189: 1914 20.
7. Suda Y, Kim YM, Ogawa T, et al. Chemical structure and biological activity of a lipid A component from Helicobacter pylori strain 206. J Endotoxin Res 2001 7: 95 104.
8. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998 66: 5964 71.
9. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+CD25 high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003 71: 1755 62.
10. Raghavan S, Fredriksson M, Svennerholm AM, Holmgren J, Suri-Payer E. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 2003 132: 393 400.
11. Akhiani AA, Schon K, Franzen LE, Pappo J, Lycke N. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J Immunol 2004 172: 5024 33.
12. Michetti P, Corthesy-Theulaz I, Davin C, Haas R, Vaney AC, Heitz M, Bille J, Kraehenbuhl JP, Saraga E, Blum AL. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994 107: 1002 11.
13. Weltzin R, Kleanthous H, Guirakhoo F, Monath T, Lee C. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine 1997 15: 370 6.
14. Kleanthous H, Myers GA, Georgakopoulos KM, et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 1998 66: 2879 86.
15. Cuenca R, Blanchard TG, Czinn SJ, Nedrud JG, Monath TP, Lee CK, Redline RW. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1996 110: 1770 5.
16. Dubois A, Lee C, Fiala N, Kleanthous H, Mehlman P, Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun 1998 66: 4340 6.
17. Lee C, Soike K, Giannasca P, Hill J, Weltzin R, Kleanthous H, Blanchard J, Monath T. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine 1999 17: 3072 82.
18. Lee C, Soike K, Hill J, et al. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine 1999 17: 1493 505.
19. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol 2001 19: 523 63.
20. Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 1999 67: 337 41.
21. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998 188: 2277 88.
22. Aebischer T, Laforsch S, Hurwitz R, Brombacher F, Meyer TF. Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice. Infect Immun 2001 69: 556 8.
23. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, Iwakura Y, Imanishi J. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 1999 67: 279 85.
24. Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal alpha(4) beta(7)-integrin-positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice. Gastroenterology 2000 119: 109 18.
25. Velin D, Bachmann D, Bouzourene H, Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 2005 129: 142 55.
26. Garhart CA, Redline RW, Nedrud JG, Czinn SJ. Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect Immun 2002 70: 3529 38.
27. Chen W, Shu D, Chadwick VS. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J Gastroenterol Hepatol 2001 16: 377 83.
28. Akhiani AA, Stensson A, Schön K, Lycke NY. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol 2005 174: 8144 53.
29. Ismail HF, Fick P, Zhang J, Lynch RG, Berg DJ. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 2003 170: 3782 9.
30. Ismail HF, Zhang J, Lynch RG, Wang Y, Berg DJ. Role for complement in development of Helicobacter-induced gastritis in interleukin-10-deficient mice. Infect Immun 2003 71: 7140 8.
31. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001 19: 683 765.
32. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 2006 117: 433 42.
33. + T cells. J Immunol 1998 160: 3188 93.
34. Sutton P, Kolesnikow T, Danon S, Wilson J, Lee A. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect Immun 2000 68: 4802 4.
35. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 2001 166: 7456 61.
36. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, Iwakura Y, Imanishi J. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immu 1999 67: 279 85.
37. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 2000 165: 1022 9.
38. Aebischer T, Walduck A, Schroeder J, Wehrens A, Chijioke O, Schreiber S, Meyer TF. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection. Int J Med Microbiol 2008 298: 161 8.
39. Demitsu T, Katayama H, Saito-Taki T, Yaoita H, Nakano M. Phagocytosis and bactericidal action of mouse peritoneal macrophages treated with leukotriene B4. Int J Immunopharmacol 1989 11: 801 8.
40. Knight PA, Wright SH, Lawrence CE, Paterson YYW, Miller HRP. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J Exp Med 2000 192: 1849 56.
41. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005 6: 135 42.
42. Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006 442: 997 1002.
43. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunol 2007 8: 1095 104.
44. Blanchard TG, Drakes ML, Czinn SJ. Helicobacter infection: pathogenesis. Curr Opin Gastroenterol 2004 20: 10 5.
45. Matsumoto Y, Blanchard TG, Drakes ML, Basu M, Redline RW, Levine AD, Czinn SJ. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Helicobacter 2005 10: 407 15.